Bolt Biotherapeutics, Inc. (BOLT) vs Co-Diagnostics, Inc. (CODX)
A side-by-side comparison of Bolt Biotherapeutics, Inc. and Co-Diagnostics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BOLT
Bolt Biotherapeutics, Inc.
$3.50HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
CODX
Co-Diagnostics, Inc.
$1.10HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
Total return — BOLT vs CODX
growth of $100 · dividends reinvested · last 6yBOLT -99.5% (-58.1%/yr)CODX -99.7% (-63.1%/yr)BOLT compounded faster over this window
BOLT CODX
BOLT vs CODX: by the numbers
- •CODX is the larger company ($7M vs $7M market cap).
- •Both run net losses; BOLT's is the smaller (-611.47% vs -6523.04% net margin).
Metrics side by side
Valuation
| Metric | BOLT | CODX |
|---|---|---|
| P/S ratio | 1.43 | 9.53 |
| P/B ratio | 0.53 | 0.54 |
Profitability
| Metric | BOLT | CODX |
|---|---|---|
| Gross margin | 80.62% | 64.28% |
| Operating margin | -450.07% | -5025.53% |
| Net margin | -611.47% | -6523.04% |
| ROE | -227.37% | -370.16% |
| ROIC | -90.17% | -219.15% |
Growth (annualized)
| Metric | BOLT | CODX |
|---|---|---|
| Revenue CAGR (5Y) | N/A | -62.43% |
| Total return CAGR (5Y) | -57.61% | -66.53% |
Frequently asked
- How have BOLT and CODX total returns compared?
- Over the past 5 years, BOLT delivered -57.61% and CODX delivered -66.53% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.